Marta Perachino Shares the Results of Study on Safety of Pregnancy after PrBC in Young BRCA carriers
Marta Perachino, X, adding:
”Out now the results of our international multicenter study evaluating the safety of a subsequent pregnancy after a diagnosis of PrBC in BRCAm patients
- 10y cumulative incidence of pregnancy 36.6%
- no differences in DFS or OS based on subsequent pregnancy status
No major concerns regarding maternal or fetal outcome with 75.9% of pregnancies delivered at term (75.9%) and without major obstetrical or fetal complications
Important evidence to support our daily counseling of young BRCA carriers diagnosed during pregnancy and still wishing to complete their family plans
Many thanks to the amazing team that made this international effort possible”
Title: Safety of having a subsequent pregnancy after prior diagnosis of breast cancer during pregnancy in young BRCA carriers
Authors: M. Perachino, E. Blondeaux, V. Delucchi, R. Bernstein Molho, S. Frank, S. Paluch-Shimon, S. Linn, A. Di Meglio, F. Peccatori, H.C.F. Moore, A. Parokonnaya, T. Renaud, K.A. Rodriguez Wallberg, A.H. Partridge, K. Pogoda, A. Ferrari, H. Wildiers, A. Toss, C. Rousset-Jablonski, H.J. Kim, M. Varela, O. Cordoba, C. Tanase Damian, M. Marhold, A. Fabi, S.L. Graff, A. Rodriguez-Hernandez, M. Okano, R. Duchnowska, H. Luna Pais, R. Di Rocco, H.A. Azim, Jr., E. Mariamidze, H.R. Kourie, L. Arecco, E. Carrasco, E. Agostinetto, J. Balmana, C. Saura, M. Lambertini
You can read the Full Article here.
More posts featuring BRCA on OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023